Introduction
Heart failure (HF) is a chronic condition that affects over 15 million people in Europe 1 and 5.7 million people in USA. 2 As the final stage of a wide variety of cardiac diseases, HF is rising in prevalence worldwide because of the aging of the population. Projections show that by 2030, 46%
of the population aged > 18 year will be affected by HF. 2 The impact of HF on the quality of life (QOL) of patients and their families is immense.
Symptom burden and depression in HF patients are comparable to that of cancer. 3 Family caregivers of HF patients experience greater levels of unmet needs than other caregiver populations. 4 Self-care has been shown to improve HF patient outcomes (e.g., QOL, hospitalizations). 5 HF self-care was defined as "a naturalistic decision-making process that influences actions that maintain physiologic stability (maintenance), facilitate the perception of symptoms (symptom perception), and direct the management of those symptoms (management)", (p. 1). 6 Self-care maintenance, symptom perception, and self-care management are mastered in sequence and prior works have already shown that self-care maintenance predicts self-care management. 7, 8 Self-care maintenance, symptom perception and management are influenced by confidence in the ability to perform self-care or task-specific self-efficacy in the self-care process. 6 Prior work Caregiver contributions to HF self-care have been defined as the "provision of time, effort, and support in behalf of another person who needs to perform HF self-care" (p. 246). 9 Although patient self-care
and caregiver contributions to self-care are important to improve patients' HF outcomes, both patients and caregivers struggle and self-care has been shown to be suboptimal. 10, 11 Trials designed to improve HF self-care have shown inconsistent results. Some studies have found that educational interventions improve self-care 12 while others have not. 13 A recent systematic review with meta-analysis 14 that included 20 randomized controlled trials (RCTs) with a total of 5624 HF patients showed that interventions designed to improve self-care were effective in reducing mortality and hospitalization; however, the authors concluded that the mechanisms by which self-care could be improved were unclear. In fact, interventions that included standardized training of interventionists, peer contact, record keeping, or goal-setting skills appeared even less effective than interventions without these characteristics. Another recent systematic review 15 of 33 studies explored the main mechanisms through which programs actually work to improve HF selfcare. Results showed that interventions may be more effective if they 1) mobilize real support from providers (e.g., establishing a good supportive relationship with patients); 2) promote self-efficacy (e.g., promoting personal confidence and hope); 3) increase insight and understanding of HF and self-care (e.g., linking symptoms to HF self-care tasks); 4) increase the involvement of other people (e.g., including a family caregiver); 5) are individualized and responsive (e.g., basing the intervention on patient need and preferences). All of these mechanistic elements are emphasized in motivational interviewing.
Motivational interviewing (MI) is a counselling technique defined as a "person-centered method of guiding to elicit and strengthen personal motivation for change" 16 (p. 25) with a collaborative and evocative approach that honors patient autonomy to elicit his/her own motivation to change behaviors in the interest of health. In fact, MI is described as the polar-opposite of giving unsolicited advice. 16 Despite the encouraging results shown above, the evidence to date is preliminary. Moreover, in the above studies, caregivers were rarely involved and few received help to improve their contributions to HF patient self-care. Caregivers are acknowledged as having a key role in helping HF patients improving self-care 10 but given that a psychometrically sound measure of this contribution was developed only in 2013 9 we do not know yet if improving this contribution with an intervention can influence HF patient self-care. Therefore, the aims of this RCT are: 1) to evaluate the effect of MI in HF patients and caregivers in improving self-care maintenance in HF patients (primary outcome); 2) to evaluate if MI in caregivers improves patient self-care over and above MI performed solely on patients; 3) to evaluate the effect of MI on the following secondary outcomes: a) in HF patients: self-care management, self-care confidence, HF somatic symptom perception, generic and disease-specific quality of life, anxiety and depression, cognition, sleep quality, mutuality with caregiver, hospitalizations, use of emergency services, and mortality; b) in caregivers: caregiver contribution to self-care, quality of life, anxiety and depression, sleep, mutuality with patient, preparedness, and social support.
Methods

Study design
This is a three-arm randomized controlled trial ( Figure 1 ) that complies with the Declaration of Helsinki, has been approved by the Institutional Review Board of the University of Rome "Tor Vergata" and has been registered at ClinicalTrials.gov (Identifier: NCT02894502). In this trial patients will be randomized in three arms: 1) MI intervention to only patients, 2) MI intervention to patients and caregivers, 3) standard of care to patients and caregivers.
Intervention MI will be delivered by registered nurses who have attended a 40-hour course on MI. This intervention will be performed in Arm 1 to only patients and in Arm 2, to both patients and caregivers. The intervention will include a first session (about 60 minutes) where the interventionist will address one or two aspects of self-care that the participants want to address. Guided by the principles of MI, the interventionist will develop discrepancy (e.g., helping the patient/caregiver to see that current behaviors would impede the ability to reach health goals), express empathy (e.g., with active listening and an attitude of acceptance), avoid arguing and direct confrontation (e.g., being respectful of patient/caregiver choices or preferences), roll with resistance (e.g., by involving patient and caregiver in problem solving) and support self-efficacy and optimism (e.g., by verbal persuasion and encouraging a focus on past successes). After this first intervention, the same interventionist will contact the participant by telephone to bolster the first intervention and provide further support as needed. These telephone contacts will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
Treatment fidelity
All interventions will be audio recorded in order to assess the quality of MI for treatment fidelity purposes as described in the Motivational Interviewing Treatment Integrity Coding Manual 4.1. 25 
Control group
Patients and caregivers in the control group (Arm 3) will receive the standard care, which in
Italy generally includes oral information on the disease and its treatment given to patients and their family members and a medical check-up every 6-12 months depending on patient condition. The control group also will be given the same informational material given to the intervention groups in arms 1 and 2.
Recruitment and eligibility assessment of study participants HF patients and caregivers will be recruited in several hospital, outpatient, and community settings across Italy. HF patients and caregivers will be assessed for study eligibility based on the following inclusion and exclusion criteria. The inclusion criteria for patients are: 1) a confirmed diagnosis of HF according to international guidelines; 1 ; 2) New York Heart Association (NYHA) functional class II-IV; 3) inadequate self-care assessed with a score of 0, 1 or 2 in at least two items of the self-care maintenance or self-care management scales of the Self-Care Heart Failure Index (SCHFI); 3) willingness to participate in the study and to sign the informed consent form. The exclusion criteria for patients are: 1) severe cognitive impairment evaluated with a score 0 -4 on the Six-item screener 26 ; 2) acute coronary syndrome event during the last three months; 4) living in a residential settings (e.g., nursing home): 5) caregiver not willing to participate in the study.
Inclusion criteria for caregivers are: 1) designated by the patient as the primary informal caregiver, that is, the person inside or outside the family who takes most of care of the HF patient;
2) Exclusion criteria for caregiver are: 1) patient not willing to participate in the study.
Baseline and follow-up assessment
Patients' and caregivers' sociodemographic characteristics will be assessed at baseline. At baseline patients also will be assessed for their HF clinical characteristics (e.g., NYHA functional class), comorbidity with the Charlson Comorbidity Index, 27 and cognition, with the Montreal Cognitive Assessment. 28 Follow-up assessment will be performed at 3, 6, 9 and 12 months after enrolment, patients and caregivers will be tested with a battery of psychometrically sound tools (Table 1 ) in order to evaluate the primary and secondary outcomes. Baseline and follow-up assessment will be performed by trained nurse research assistants, who are blinded to group and different than those who perform MI.
Randomization and blinding
After enrolment and baseline data collection, each patient-caregiver dyad will be randomized (1:1:1) to one of the three arms. Randomization will be done at the University of Rome
Tor Vergata with the use of an informatics software program that will generate randomization lists.
Outcome measures
Primary outcome
The primary outcome of this RCT will be HF self-care maintenance in patients that will be measured with the Self-Care Maintenance Scale of the Self-Care of HF Index version 6.2 (SCHFI). 29 The SCHFI is an instrument used worldwide to measure the self-care dimensions of maintenance and management. The Self-Care Maintenance Scale captures HF symptom monitoring (e.g., weighting every day) and treatment adherence (e.g., taking medications as prescribed) and was tested for its validity and reliability 29 . The Self-Care Maintenance Scale yields a score from 0 to 100 with higher scores meaning better self-care maintenance. The primary outcome of self-care maintenance of patients will be evaluated 3-months from the enrolment. Also, we will evaluate HF patient self-care maintenance at 6, 9 and 12 months from the enrolment.
Secondary outcomes
Several secondary outcomes will be evaluated with a battery of tools, all with established validity and reliability (Table 1) . Specifically, in patients we will use: the Self-Care Management 35 to evaluate the relationship between the patient and caregiver. In caregivers we will use: the Caregiver Contribution to Self-Care of HF Index (CC-SCHFI) 9 , that investigates the extent to which caregivers recommend to patients to perform self-care or perform self-care on behalf of the patients if they are unable to do so; the SF-12; the Hospital Anxiety and Depression Scale; 33 the Pittsburgh Sleep Quality Index; 34 the Mutuality scale-caregiver version to evaluate the relationship with the patient; 36 the Caregiver Preparedness Scale, 37 which measures caregiver preparedness to meet the patient's physical and psychological needs; the Multidimensional Scale of Perceived Social support. 38 At each follow-up, caregivers will be asked about patient hospitalization, use of emergency services and death. All secondary outcomes will be evaluated baseline and 3, 6, 9 and 12 months after the enrollment (Table 1) .
Statistical analysis
Sample size: A total sample of 240 subjects (80 per each group) achieves 90% power to detect a 8% difference in self-care maintenance 39 obtained by patients at 3 months with MI intervention (arms 1 and 2, with a mean self-care maintenance of 63) versus patients in standard care (arm 3 with a mean self-care maintenance of 55) using an F test with a 0.05 significance level (one-way ANOVA). The common standard deviation within a group is assumed to be 18. 20 The sample of 240 subjects will also provide 83% power to detect a 8% difference in patient self-care management and self-care confidence at 3 months in arm 1 and 2 versus 3, assuming a standard deviation of 20. 39 Based on the available literature and in order to account for an estimated 50% attrition rate 20 , 480 participants (240 patients and 240 caregivers) will be recruited. As far as the evaluation of MI in caregivers (aim 2), group sample sizes of 80 achieve 80% power to detect a difference of 8 points of caregiver selfcare maintenance and with estimated group standard deviations of 18 and with a significance level of 0.05 using a two-sided two-sample t-test. As for patient self-care management and self-care confidence, with an expected group standard deviations of 20, the power for aim 2 is 71%.
Planned statistical analysis: Measures of central tendency and of variability will be used to describe HF patient and caregiver characteristics as well as the outcome measure scores. For the primary end-point a one-way ANOVA will be used comparing arm 1 and 2 with arm 3. A two-sample t-test will be used to compare self-care of participants in arm 1 and 2 to evaluate MI in caregivers. The percentage of patients with a SCHFI score over 70 39 will be compared with the Chi-square test. A longitudinal linear regression model will be used to evaluate the trend of Self-Care in the three arms. Secondary outcomes will be evaluated with ANOVA.
Discussion
The aim of this RCT is to evaluate the effect of MI in improving self-care maintenance in HF patients. Also, this study will allow us to see if MI has an effect on other secondary variables, such as, in patients: self-care management, self-care confidence, symptom perception, quality of life, anxiety and depression, cognition, sleep quality, mutuality with caregiver, hospitalizations, use of emergency services, and mortality; in caregivers: caregiver contribution to self-care, quality of life, anxiety and depression, sleep, mutuality with patient, preparedness, and social support.
Self-care may improve patient outcomes 5 but investigators have found that self-care is low in several populations 11, 40, 41 . Despite well designed studies conducted to improve self-care, these studies have not always had good results. However, a recent systematic review 15 and mixed method study 24 improved our understanding of the mechanisms through which programs actually work to improve HF self-care. In this systematic review, it was shown that interventions to improve HF patient self-care may be more effective if a good supportive relationship is established between the patient and the provider, if the interventions focus on self-efficacy and increasing understanding of the disease, involve other supportive people, and are individualized. In the mixed method study, it emerged that the development of discrepancy and self-efficacy were the main mechanisms involved in changes in self-care. All the above aspects are emphasized in motivational interviewing.
Several studies conducted in other patient populations 18 have demonstrated that MI can be effective in facilitating behavioral change, but, to our knowledge, in HF only 5 studies with small samples have been published [21] [22] [23] [24] [25] . These studies have been promising, with improvements in selfcare maintenance, self-care confidence, quality of life and hospital readmission. Differently from other studies so far conducted with MI, in our study we will also use MI with the caregivers since they have a key role in contributing to HF care. 10 Also, differently from other studies using MI, in our secondary outcomes, we will follow-up patients' self-care and caregivers' contributions to selfcare over one year, so that we can see if MI has a long lasting effect and, if so, on which variables.
In this way we can also evaluate the "dose" of MI in order to personalize future interventions. For example, based on the trajectory of self-care and caregiver contribution to self-care, we can see when MI is needed in order to keep self-care sufficiently high. We demonstrated in prior work 42 that, in order to significantly reduce mortality and rehospitalizations, self-care maintenance, management and confidence scores should be around a standardized score of 70 (0-100 possible range). These scores are not easy to reach since in most of studies the self-care maintenance, management and confidence scores were approximately 50. 43 It has been suggested that an MI intervention could be expensive for health-care organizations to provide, since nurses spend a lot of time providing the intervention. Masterson
Creber et al and Riegel et al 21 have shown that a brief MI session can improve self-care maintenance and can reduce hospitalizations at three months from the intervention. Even though these investigators have seen the effect of MI in a short period of time, their intervention was potentially cost effective since, as we will do in this study, they performed only one session with MI and three follow-up calls to bolster the intervention.
Conclusion
HF is a debilitating illness anticipated to increase in prevalence in the future because the aging of the population. It was shown that around the 7% of the total health-care budget are for HF care in developed countries. 44 As the population is aging, we can anticipate that health-care
expenditures for HF will only rise in the future. Self-care can improve patients' condition and reduce readmissions but improving self-care is not easy. This study will determine if MI could help HF patients and their caregivers to improve their self-care sufficiently to reduce the burden of the illness. The next step will be to determine if this intervention is also cost-effective.
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